COGNICURRENT

Chinese exporters are uncertain about their business with Iran due to recent US and Israeli military strikes, resulting in halted shipments and unresponsive clients.

Chinese tech firms, including Baidu, WeRide, and Meituan, are halting operations or adopting remote work policies in the Middle East due to escalating security risks from the Iran war.

Analysts predict that Chinese firms are set to gain significant profits from the global shift towards clean energy infrastructure investment.

Hong Kong-listed Chinese pharmaceutical companies are expected to experience profit growth driven by increased sales of innovative drugs and favorable licensing agreements despite existing pricing challenges.

Chinese high-speed railway firms are looking to expand their operations into Eurasia as the domestic market reaches saturation, with various international projects on the horizon.

Chinese technology firms have showcased advanced AI tools during the Winter Olympics, enhancing viewer experience with innovative replays.

Pantheon Tanker, part of Anna Angelicoussis' group, is rapidly expanding its shipbuilding program by ordering new Very Large Crude Carriers (VLCCs) from Chinese firms.

The Nigerian National Petroleum Company has signed a Memorandum of Understanding with Chinese firms to enhance Nigeria's gas infrastructure through collaborative efforts across the natural gas value chain.

Trump is considering a framework for allowing Chinese car manufacturers to enter the U.S. market, involving joint ventures with American firms.

The Pentagon initially added several Chinese firms to a military list but later withdrew the filing, signaling mixed messages from the U.S. government ahead of a summit between Trump and Xi.

Chinese healthcare companies are expanding internationally to cater to the needs of their expatriate communities in regions like the Middle East and Southeast Asia.

German firms are increasingly investing in China due to diminished confidence in the US stemming from Trump's policies, despite facing challenges in the Chinese market.

The market share of South Korea's three major battery firms—LG Energy Solution, SK On, and Samsung SDI—declined by 3.3% despite a global increase in electric vehicle battery usage, largely due to the growing dominance of Chinese competitors.

Chinese AI companies assert their safety protocols and argue that their approaches should be understood within their cultural context, attempting to counter Western critiques as they close the competitive gap with U.S. firms.

Chinese robotics companies are experiencing a funding surge, particularly in developing humanoid intelligence systems supported by state-backed funds and major tech firms.

Chinese firms are encouraged by industry leaders to adapt to local markets abroad as they seek international sales opportunities.

Western companies are exercising caution regarding the rise of Chinese AI, driven by concerns about reputational risk, as firms like DeepSeek and Alibaba capture significant market shares.

Chinese companies will face increased expenses due to a new 25 percent tariff on advanced AI chips imported from the US, according to analysts.

The Chinese government has instructed local companies to stop using security software developed by American or Israeli firms, affecting over 12 companies including VMware and Palo Alto Networks, leading to a significant drop in their stock prices.

Chinese entrepreneurs in Latin America remain cautiously committed despite recent political turmoil following the abduction of former Venezuelan president Nicolas Maduro.

The article discusses Venezuela's oil export strategies, particularly how firms Vitol and Trafigura plan to engage Indian and Chinese markets, the intentions of Indian refineries, and the impact of renewed Venezuelan oil exports on the global energy market.

In 2025, Chinese companies, led by Shanghai-based AgiBot, dominated the global humanoid robot market, capturing nearly 38% of the shipments and surpassing major American firms.

India is set to lift restrictions that have prevented Chinese firms from bidding on government contracts, which were put in place following a border clash in 2020.

Mainland Chinese medicine companies are seeking to raise capital through initial public offerings in Hong Kong to support their international growth strategies.

China and South Korea have signed US$44 million in trade agreements, marking an effort to mend ties after years of strained relations, with participation from major Chinese tech firms and provincial representatives.